Google
ABT Stock Analysis — ABBOTT LABORATORIES (Healthcare >> Medical Devices)
ABT FAQ
What is ABT's P/E ratio?
ABBOTT LABORATORIES (ABT) currently trades at a P/E ratio of 33.69.
What is ABT's ROE?
ABBOTT LABORATORIES reports a Return on Equity (ROE) of 10.61%.
What is ABT's dividend yield?
ABBOTT LABORATORIES offers a dividend yield of 2.30%.
What is ABT's Quality Score?
Our AI rates ABT's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ABT?
Our AI Timing Score for ABT is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ABT belong to?
ABBOTT LABORATORIES is classified under the Healthcare >> Medical Devices sector on the NYSE exchange
ABT AI Analysis Summary
Our AI summary for ABT: ABBOTT LABORATORIES (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 33.69, ROE of 10.61%, a dividend yield of 2.30%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 105.70
Price
0.09
(0.09%)
Day Change
|
|
|---|
ABT, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.12 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
1652
|
| Magic Formula Rank by ROE |
1652
|
| Magic Formula Rank by ROIC |
1910
|
| Price | 105.70 |
| PBV / Sector |
3.53 / -101.57
|
| Earning Per Share | 3.14 |
| PE / Sector |
33.69 / 31.23
|
| PEG or PE/Growth / Sector |
1.52 / 0.40
|
| Average 1M Daily Value |
1,074.84 M
GREAT
|
| Average 1W Daily Value |
1,009.31 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
54% |
| Ability to Make Profit |
|
66% |
| Return to Investors |
|
41% |
| Registration Details |
| Analyze Date | 2026-08-01 07:59:25 |
| Symbol | ABT |
| Name | ABBOTT LABORATORIES |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 1,730.38 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 182,745.79 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400
Phone: 224 667 6100
Website: https://www.abbott.com
Employees: 122,000
Sector: Healthcare >> Medical Devices
Description: Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
